Vial Announces $67M Series B Led by General Catalyst
Read Vial's feature in the WSJ

Postmenopausal Osteoporosis

What is Postmenopausal Osteoporosis? Postmenopausal osteoporosis is age-related loss of bone tissue, causing bones to become brittle in postmenopausal women. The hormonal changes, specifically the decrease in estrogen after menopause, increase the rate of bone loss significantly. Osteoporosis is a common and often silent condition, affecting 1 in 10 women over the age of 60, and increasing the risk of fracture by 50%. Fractures in the elderly decrease the quality of life, increase risk of more fractures, and increase mortality.

Risk factors for Postmenopausal Osteoporosis

  • Advanced age
  • Family history of fractures
  • Low body weight
  • Caucasian or Asian ethnicity
  • Vitamin D deficiency
  • Low calcium diet
  • Lack of exercise
  • Cigarette smoking
  • Excessive use of alcohol
  • Use of glucocorticoids
  • History of rheumatoid arthritis

Source: Endocrine Society. (2022, March 31). Osteoporosis. Retrieved June 2, 2022, from https://www.endocrine.org/patient-engagement/endocrine-library/osteoporosis